Jupiter Topco LLC Takes Position in LifeStance Health Group, Inc. $LFST

Jupiter Topco LLC bought a new position in LifeStance Health Group, Inc. (NASDAQ:LFST) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 94,500 shares of the company’s stock, valued at approximately $1,013,000.

A number of other hedge funds also recently made changes to their positions in the company. Larson Financial Group LLC increased its stake in LifeStance Health Group by 19,952.6% in the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock worth $27,000 after acquiring an additional 3,791 shares during the last quarter. KBC Group NV purchased a new position in shares of LifeStance Health Group in the first quarter valued at $29,000. EverSource Wealth Advisors LLC increased its position in LifeStance Health Group by 359.1% in the first quarter. EverSource Wealth Advisors LLC now owns 6,909 shares of the company’s stock worth $44,000 after purchasing an additional 5,404 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in LifeStance Health Group by 615.3% during the first quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock valued at $59,000 after purchasing an additional 7,987 shares in the last quarter. Finally, Assetmark Inc. lifted its position in LifeStance Health Group by 17.0% during the first quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock valued at $60,000 after purchasing an additional 1,367 shares during the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on LFST. Weiss Ratings raised shares of LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, August 11th. JPMorgan Chase & Co. increased their price target on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company a “neutral” rating in a report on Friday, August 14th. Wall Street Zen cut LifeStance Health Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Barclays raised their price objective on LifeStance Health Group from $9.00 to $13.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Finally, KeyCorp lifted their target price on LifeStance Health Group from $11.00 to $13.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $12.38.

LifeStance Health Group Stock Down 0.8%

Shares of NASDAQ LFST opened at $12.73 on Friday. LifeStance Health Group, Inc. has a 52-week low of $4.77 and a 52-week high of $13.15. The firm has a market capitalization of $4.94 billion, a price-to-earnings ratio of 97.93 and a beta of 1.22. The stock has a 50 day moving average price of $11.49 and a 200 day moving average price of $8.80. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.38 and a current ratio of 1.38.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.03 by $0.03. The company had revenue of $435.35 million for the quarter, compared to the consensus estimate of $414.58 million. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.LifeStance Health Group’s quarterly revenue was up 26.1% on a year-over-year basis. During the same period last year, the business posted ($0.01) EPS. Sell-side analysts expect that LifeStance Health Group, Inc. will post 0.16 earnings per share for the current year.

Insider Transactions at LifeStance Health Group

In related news, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of LifeStance Health Group stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $10.62, for a total value of $144,890,858.34. Following the completion of the sale, the insider directly owned 98,101,407 shares in the company, valued at $1,041,836,942.34. The trade was a 12.21% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO Lisa Miller sold 47,912 shares of the company’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $10.85, for a total transaction of $519,845.20. Following the completion of the sale, the chief operating officer directly owned 281,289 shares of the company’s stock, valued at approximately $3,051,985.65. This trade represents a 14.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 14,671,917 shares of company stock valued at $155,493,415. Insiders own 3.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.